Next Article in Journal
Functional Alignment Philosophy in Total Knee Arthroplasty—Rationale and Technique for the Valgus Morphotype Using an Image Based Robotic Platform and Individualized Planning
Previous Article in Journal
Association between Regional Body Muscle Mass and Non-Alcoholic Fatty Liver Disease: An Observational Study Using Data from the REACTION Study
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JPM
Volume 13
Issue 2
10.3390/jpm13020211
jpm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Depressive Symptoms during Pregnancy: Prevalence and Correlates with Affective Temperaments and Psychosocial Factors

by
Marianna Mazza
1,†,
Carla Avallone
1,†,
Georgios Demetrios Kotzalidis
1,2,*,
Giuseppe Marano
1,
Lorenzo Moccia
1,
Anna Maria Serio
3,
Marta Balocchi
1,
Ilenia Sessa
1,
Delfina Janiri
1,
Ilaria De Luca
1,
Caterina Brisi
1,
Maria Chiara Spera
1,
Laura Monti
3,
Angela Gonsalez del Castillo
3,
Gloria Angeletti
2,
Daniela Chieffo
3,
Lucio Rinaldi
1,
Luigi Janiri
1,
Antonio Lanzone
4,
Giovanni Scambia
5,
Eugenio Maria Mercuri
6 and
Gabriele Sani
1add Show full author list remove Hide full author list
1
Institute of Psychiatry and Psychology, Department of Geriatrics, Neuroscience and Orthopedics, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
2
NESMOS Department (Neurosciences, Mental Health, and Sensory Organs), Faculty of Medicine and Psychology, Sapienza University of Rome, 00189 Rome, Italy
3
Unit of Clinical Psychology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
4
Department of Obstetrics and Gynaecology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
5
Division of Gynecologic Oncology, Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
6
Paediatric Neurology Unit, Fondazione Policlinico Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
J. Pers. Med. 2023, 13(2), 211; https://doi.org/10.3390/jpm13020211
Submission received: 11 December 2022 / Revised: 12 January 2023 / Accepted: 24 January 2023 / Published: 25 January 2023
(This article belongs to the Section Personalized Therapy and Drug Delivery)
Browse Figure
Review Reports Versions Notes

Abstract

:
Pregnancy is a unique experience in women’s life, requiring a great ability of adaptation and self-reorganization; vulnerable women may be at increased risk of developing depressive symptoms. This study aimed to examine the incidence of depressive symptomatology during pregnancy and to evaluate the role of affective temperament traits and psychosocial risk factors in predicting them. We recruited 193 pregnant women, collected data regarding sociodemographic, family and personal clinical variables, social support and stressful life events and administered the Mood Disorder Questionnaire (MDQ), the Patient Health Questionnaire-9 (PHQ-9), and the Temperament Evaluation of Memphis, Pisa, Paris and San Diego-Autoquestionnaire (TEMPS-A). In our sample, prevalence of depressive symptomatology was 41.45% and prevalence of depression was 9.85% (6.75% mild and 3.10% moderate depression). We have chosen a cutoff >4 on PHQ-9 to identify mild depressive symptoms which may predict subsequent depression. Statistically significant differences between the two groups were found in the following factors: gestational age, occupation, partner, medical conditions, psychiatric disorders, family psychiatric history, stressful life events, and TEMPS-A mean scores. In our sample mean scores on all affective temperaments but the hyperthymic, were significantly lower in the control group. Only depressive and hyperthymic temperaments were found to be, respectively, risk and protective factors for depressive symptomatology. The current study confirms the high prevalence and complex aetiology of depressive symptomatology during pregnancy and suggests that affective temperament assessment seems to be a useful adjunctive instrument to predict depressive symptomatology during pregnancy and postpartum.

1. Introduction

Pregnancy is a unique experience in women’s life, a complex bio-psycho-social process, characterized by anatomical, physiological, biological, psychological, and social changes. This critical period requires a great ability of adaptation and self-reorganization; vulnerable women may be at increased risk of developing depressive symptoms. The prevalence of prenatal depression is estimated to range from 7% to 20% in high income countries [1]. Results of an umbrella review show high prevalence of antenatal depression, especially in low income countries, ranging from 15% to 65% [2]. Depression during pregnancy has been linked to hypertension, preeclampsia, gestational diabetes, preterm birth, low birth weight, foetal growth restriction, postnatal complications as well as negative impact on child development [2,3].
In a systematic review, maternal anxiety, life stress, history of depression, lack of social support, unintended pregnancy, Medicaid insurance, domestic violence, lower income, lower education, smoking, single status, and poor relationship quality showed associations with antenatal depressive symptoms [4]. A recent review identified three main groups of antenatal depressive risk factors: sociodemographic, obstetric, and psychological ones. Among these variables, the main ones were low level of education and income, unplanned pregnancy, history of psychological disorders, depression, anxiety, and low social support during pregnancy [5].
Temperament refers to the temporally stable biological ‘core’ of personality and may be seen as a bridge between the psychology and the biology of affective disorders [6]. Akiskal and colleagues developed a five affective temperaments model (depressive, cyclothymic, hyperthymic, irritable, and anxious) and the TEMPS-A, a psychometric instrument to assess them [7]. Research shows that up to 20% of the population has some kind of marked affective temperaments which may be considered subclinical forms and antecedents of mood disorders [6]. A meta-analysis, evaluating affective temperaments, suggests a continuum model of affective temperament domains spanning from healthy controls to mood disorders [8]. Affective temperaments could also play a pathoplastic role influencing the emergence and clinical evolution of affective disorders and their characteristics: predominant polarity, symptomatic expression, long-term course and consequences, response and adherence to treatment and outcome as well [9].
To the best of our knowledge, few studies have investigated affective temperaments during pregnancy. The present study aimed to examine the incidence of depressive symptomatology during pregnancy and to investigate the role of affective temperament traits and other possible psychosocial risk factors in predicting depression.

2. Materials and Methods

This cross-sectional study was conducted from July 2020 to November 2021. We consecutively recruited 200 pregnant women at the Gynaecology and Obstetrics Day Hospital of the Fondazione Policlinico Universitario A. Gemelli IRCCS. Exclusion criteria were age less than 18 years old, failure to provide free informed consent, diagnosis of psychosis, and incomplete comprehension of the Italian language that prevented women from completing the study protocol. Overall, of the 200 eligible women, 193 participated in the study; five refused to sign the consent form and two were not sufficiently fluent in Italian. At assessment we performed the completion of a sociodemographic data collection form, including family and personal clinical variables, and the administration of specific questionnaires. We also collected data regarding social support and stressful life events by posing specific questions as delineated in Paykel et al. [10]. Specifically, women were asked about conflicts with their family of origin, about their marital adjustment, and about past events that might have affected their pregnancy (i.e., loss of a significant other, life-threatening disease or event in oneself or significant other, professional stress, and economic hardship) and the timing and perceived intensity of each event was recorded by the interviewing clinician. Eventually, each woman was classified as having or not having social support and as having or not having a history of stressful life events. We also administered the Mood Disorder Questionnaire, the Patient Health Questionnaire-9, and the Temperament Evaluation of Memphis, Pisa, Paris and San Diego-Autoquestionnaire.
The Mood Disorder Questionnaire (MDQ) is a questionnaire developed by Hirschfeld et al. as screening instrument for bipolar disorders. It is based on DSM-IV criteria and consists of 3 “yes/no” questions. The first one examines the lifelong history of manic or hypomanic symptoms and consists of 13 items. The second question explores the occurrence of symptoms during the same period and the third one how significantly they impacted on daily functioning. Positive screen requires 7 or more symptoms, multiple symptoms occurring at the same time, and notable psychosocial impairment [11,12]. We used the validated Italian version of the MDQ [13].
The Patient Health Questionnaire-9 (PHQ-9) is based on DSM-IV criteria to assess the presence of depressive symptoms in the preceding 2 weeks. It consists of 9 questions scored from 0 (not at all) to 3 (nearly every day), for a total score ranging from 0 to 27. A score of 0–4 is considered as having minimal depressive symptoms, 5–9 mild depressive symptoms, 10–14 mild depression, 15–19 moderate depression, 20–27 severe depression [14,15]. We used the validated Italian version of the PHQ-9 [16]. Based on the results obtained on this instrument, we subdivided the sample into two subgroups; women scoring 4 or less entered the PHQ-9 ≤4 group, while those scoring >4 were considered the symptomatic group, independently from the severity of their depression.
The Temperament Evaluation of Memphis, Pisa, Paris and San Diego-Autoquestionnaire (TEMPS-A) was used to assess the five affective temperaments in psychiatric and healthy subjects: depressive (D), cyclothymic (C), hyperthymic (H), irritable (I), and anxious (A). It is an autoquestionnaire that contains 110 “true” or “false” items. The highest score is considered to indicate the prevailing temperament [7]. We used the validated Italian version of TEMPS-A [17]. The research protocol was approved by the Ethical Committee of Fondazione Policlinico Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy (Protocol ID:2221).

3. Statistical Analysis

We subdivided our sample into two groups according to the PHQ-9 cut-off score >4, i.e., a PHQ-9 ≤4 and a PHQ >4 group. Analyses used standard comparisons of continuous measures (ANOVA) and categorical measures (contingency table/χ2) to compare factors of interest in the two groups. Factors significantly associated with depressive symptomatology underwent a binomial logistic regression to generate Odds Ratios (ORs) and their 95% Confidence Intervals (CIs). We examined possible collinearity between variables of interest by ensuring that the variance inflation factor (VIF) indicator obtained from linear regression analysis was <3.5. We used the statistical routines of the SPSS (Statistical Package for the Social Sciences) 24.0 for Windows software (IBM Co., Armonk, New York, NY, USA, March 2016).

4. Results

In our sample (n = 193), nobody reached the severe depression cut-off score on the MDQ and were divided into two groups according to their scores on the PHQ-9: 113 (58.55%) scored 4 or lower (mean = 2.32 ± 1.33), 80 (41.45%) higher than 4 (mean = 8.20 ± 3.20) (Figure 1). Thus, the >4 on the PHQ-9 group comprised women with mild depressive symptoms, mild depression, and moderate depression. Prevalence of depressive symptomatology was distributed as follows: mild depressive symptoms n = 61 (31.60%), mild depression n = 13 (6.75%) and moderate depression n = 6 (3.10%). Nobody scored 20 or higher.
Sociodemographic variables, epidemiologic characteristics and temperament scores are shown in Table 1.
Statistically significant differences between the two groups were found in the following factors: gestational age (χ2 = 6.32; p = 0.042), occupation (χ2 = 4.92; p = 0.027), partner (χ2 = 4.48; p = 0.034), medical conditions (χ2 = 4.17; p = 0.041), psychiatric disorders (χ2 = 11.5; p < 0.001), family psychiatric history (χ2 = 5.71; p = 0.017), stressful life events (χ2 = 5.11; p = 0.024), TEMPS-A depressive (F = 42.20; p < 0.001), TEMPS-A cyclothymic (F = 16.36; p < 0.001), TEMPS-A hyperthymic (F = 16.49; p < 0.001), TEMPS-A irritable (F = 21.66; p < 0.001), and TEMPS-A anxious (F = 38.60; p < 0.001).
In the PHQ-9 ≤4 group, mean age was 35.39 ± 5.50 years, ranging 20–45 years. In this sample, there were 107 Italian citizens (94.70%) and 6 foreigners (5.30%). In the PHQ-9 >4 group mean age was 33.77 ± 6.07 years, ranging 19–45 years. There were 73 Italian citizens (91.25%) and 7 foreigners (8.75%). Results for sociodemographic and clinical variables are shown in Table 1. Briefly, the two groups did not differ for age, although the PHQ-9 >4 tended to be nominally older. The distribution per trimester showed the PHQ-9 >4 group to have more pregnant women in the first trimester, but this finding is not strong (p = 0.04). Having a job and a partner was more frequent in the PHQ-9 ≤4 group, while having a past medical condition, a lifetime psychiatric disorder, a family psychiatric history, and past stressful life events was more frequent in the PHQ-9 >4 group. Stressful life events were present in 52 (46%) of women in the PHQ-9 ≤4 group [job loss n = 11 (9.73%), mourning n = 6 (5.31%), economic difficulties n = 5 (4.42%), intracouple conflicts n = 2 (1.76%), conflicts with family of origin n = 1 (0.88%), severe disease or accident of a family member n = 3 (2.65%), multiple stressful life events n = 24 (21.24%)] and in 50 women (62.5%) [job loss n = 5 (6.25%), mourning n = 7 (8.75%), economic difficulties n = 2 (2.5%), intracouple conflicts n = 4 (5%), severe disease or accident of a family member n = 4 (5%), multiple stressful life events n = 28 (35%)] in the PHQ-9 >4 group. Social support types were no support, n = 5 (4.4%), support by a partner, n = 6 (5.31%), support by relatives/friends, n = 18 (15.92%), and multiple support, n = 84 (74.33%) in the PHQ-9 ≤4 group, and no support, n = 2 (2.5%), support by partner, n = 5 (6.25%), support by relatives/friends, n = 28 (35%), and multiple support (i.e., by all of the above) n = 45 (56.25%) in the PHQ-9 > 4 group; overall, support type did not differ between the two groups, but there were more women with multiple support in the PHQ-9 ≤4 group at the expense of the support by relatives/friends type, which, however, merged into the multiple support type in this group.
Logistic regression of TEMPS-A affective temperaments identified the depressive temperament (OR: 1.310; p= 0.006) as a risk factor and hyperthymic temperament as a protective factor (OR: 0.871; p = 0.005) for depressive symptomatology during pregnancy. Results are shown in Table 2 and Table 3.
In our sample, there were eleven patients with current medical conditions (four hypertension, three diabetes, two fibromyalgia, and two generalised anxiety disorder); six were in the PHQ-9 ≤4 group and five in the PHQ-9 >4 group, with conditions about equally distributed. These patients were on antihypertensive medication (two nifedipine and labetalol and two methyldopa), pregabalin (four patients with fibromyalgia or generalised anxiety disorder), and oral hypoglycaemics (two metformin and one glibenclamide). Due to the low occurrence of significant medical conditions in our sample (5.7%), it is unlikely that drug intake could have affected results.

5. Discussion

Many studies show a significant presence of depressive symptomatology during pregnancy suggesting that monitoring mental health in this particular period should be considered a major public health issue. Antenatal depression has been found to constitute the strongest predictor of postnatal depression, which in turn predicts parenting stress [18]. Furthermore, maternal depression has a negative impact on physical, emotional, cognitive, behavioural, and social child development [19]. An Italian study found depressive symptomatology in 30.87% of women during the second trimester of pregnancy [20]. We here found more women in the PHQ-9 >4 group to belong to the first trimester, that could mean that the more severe group develops depressive symptoms early in pregnancy (or carries them over from the preceding period). A meta-analysis has indicated that depression has a prevalence of 25.6% in pregnant women during the COVID-19 pandemic [21]. A recent review reported that globally, perinatal mental health has worsened during the COVID-19 pandemic regardless of infection status [22].
In our sample, the prevalence of depressive symptomatology was 41.45% and that of depression was 9.85% (6.75% mild and 3.10% moderate depression). Our results are in line with findings by Biaggi et al. [1] but lower than the rate reported by Tomfohr-Madsen et al. [21]. A possible explanation might be the positive effect of periodic follow-up visits and decreased perception of pandemic, in that specific period, in Italy. Another explanation could be the resilience provided by expecting a child, which correlates with perceived stress and anxiety [23,24]. In fact, higher perceived stress and anxiety have been observed in prepandemic samples, compared to samples after the breakthrough of the pandemic [25,26,27], which we attributed to the increased ability of pregnant women to cope with novel generalised threats and mobilise inner resources, such as those related to resilience [26], probably based on increased brain plasticity, which is induced by pregnancy [27].
We have chosen a cut-off of >4 to identify mild depressive symptoms which may predict subsequent depression. Statistically significant differences between the two groups were found in gestational age, having an occupation, having a partner, past (lifetime) medical conditions, lifetime psychiatric disorders, family psychiatric history, stressful life events, and TEMPS-A mean scores. While having a job and a partner and being devoid of medical or psychiatric conditions and past stressful situations may intuitively boost resilience and increase the coping abilities of a person [28,29,30], thus reducing the severity of depressive symptoms [31], the different distribution of PHQ-9 ≤4 and PHQ-9 >4 in the three trimesters is more difficult to explain. It might be that women scoring >4 on the PHQ-9 carried their depressive symptoms over the period preceding pregnancy, or that they were more susceptible than women scoring ≤4 and developed depressive symptoms sooner.
In the symptomatic (PHQ-9 >4) group we found more stressful life events, particularly more multiple events, mourning, intracouple conflicts, and severe disease or accident of a family member. Job loss, economic difficulties, and conflicts with family of origin were present less often. Loss of job and economic difficulties may be addressed to a certain extent by social support [32,33], while conflicts with family of origin have a lesser impact compared with intracouple conflicts, although the two are interrelated [34].
Regarding the presence of support, we found no statistically significant differences between the PHQ-9 ≤4 and the PHQ-9 >4 groups (95.6% vs. 97.5%, respectively). With regard to the type of support, our findings showed similar rates in partner support, but more support from relatives/friends in the symptomatic (PHQ-9 >4) group (15.92% vs. 35%) and more multiple support in the PHQ-9 ≤4 group (74,33% vs. 56.25%). This might suggest that different types of support are not equivalent and it might be interesting to investigate it in a larger sample. Notably, with regard to the partner, there were statistically significant differences between the two groups (99.1% vs. 93.8%). This result is consistent with findings suggesting that a stable couple relationship is a protective factor from depression [35,36]. However, we should note that multiple support, which was preponderant in the no or minimal depressive symptoms (PHQ-9 ≤4) received all other support cases and this has determined the higher prevalence of support from relatives/friends in the more disadvantaged PHQ-9 >4 group.
Some studies have reported that depressive episodes are more frequent during the first and the third trimesters of pregnancy, probably as a consequence of stress of coping with becoming mothers and start a new life [1]. A review found that the prevalence of depression during the first trimester of pregnancy is similar to the prevalence in general population, but it is double during the second and third trimesters [37]. Another review showed that prenatal depression is more prevalent during the third trimester and less during the second one [38]. We found that the second trimester was the most frequent in both groups, but the first trimester was more represented in the symptomatic group for the reasons we hypothesised above.
Studies have shown that although many women with a past history of depression do not recur during the perinatal period, pregnancy is a time of life that should be carefully monitored [39,40]. In our sample, the different rate of psychiatric disorders lifetime between the two groups was statistically significant. Positive family psychiatric history was also more represented in the PHQ-9 >4 group.
Few studies have investigated the possible correlation of affective temperaments with mood disorders during the perinatal period. In our sample, mean scores on all affective temperaments but the hyperthymic were significantly lower in the less symptomatic PHQ-9 ≤4 group. Only depressive and hyperthymic temperaments were found to be a risk and a protective factor, respectively, for depressive symptomatology. Our results are consistent with a study that compared pregnant and non-pregnant women. One study has shown that women with bipolar disorder are at a higher risk of manic/mixed episodes during pregnancy, while their risk for developing a depressive episode is reduced [39]. Another study has shown that pregnancy favours hyperthymia and suggested that hyperthymic temperament might be protective for depressive symptomatology during this particular period of life [41]. In our groups, women screened negative for bipolar disorder. It could be hypothesized that different combinations of affective temperamental domains as well as psychosocial factors could represent vulnerability markers and help differentiating mood disorders. A study reported that hyperthymic temperament also seems to be a protective factor in the postpartum period [42]. Another one identified cyclothymic and anxious temperaments as possible risk factors for postpartum depression, independently from psychosocial factors [43]. In our sample, scores on both temperaments were lower in the PHQ-9 ≤4 group. Anxious, cyclothymic, depressive, and irritable temperaments were found to be related to more dysfunctional sleep patterns during the perinatal period [44]. Pregnancy seems to independently and negatively predict irritable, anxious, and cyclothymic temperament [45]; our results on the PHQ-9 ≤4 group are consistent with these findings.

6. Conclusions

This study confirmed a high prevalence of depressive symptomatology during pregnancy, indicating a complex aetiology. Mental health routine screenings during pregnancy should be implemented to identify vulnerable women and provide preventive and supportive interventions. It is fundamental to identify specific risk factors to develop adequate screening tools. Our results suggest that affective temperaments assessment could be a useful adjunctive instrument to predict depressive symptomatology during the peripartum period, although due to its length it cannot be recommended as a basic screen. A shorter version or a new, short questionnaire could be developed and included in basic screening. Affective temperament is a concept to incorporate in interviewing pregnant women with mood disturbances.

Author Contributions

M.M., C.A., G.D.K. and G.M. designed the study and wrote the first draft of the manuscript. C.A. and A.M.S. managed the literature searches. L.M. (Lorenzo Moccia) and D.J. performed statistical analyses. M.B., I.S., I.D.L., C.B., M.C.S., L.M (Laura Monti)., A.G.d.C., G.A., D.C., L.R., L.J., A.L., G.S. (Giovanni Scambia), E.M.M. and G.S. (Gabriele Sani) supervised and added important contributions to the paper. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee of Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy (ID 2221).

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available upon reasonable request to the corresponding author.

Conflicts of Interest

All authors declare no conflict of interest.

References

  1. Biaggi, A.; Conroy, S.; Pawlby, S.; Pariante, C.M. Identifying the women at risk of antenatal anxiety and depression: A systematic review. J. Affect. Disord. 2016, 191, 62–77. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Dadi, A.F.; Miller, E.R.; Bisetegn, T.A.; Mwanri, L. Global burden of antenatal depression and its association with adverse birth outcomes: An umbrella review. BMC Public Health 2020, 20, 173. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Becker, M.; Weinberger, T.; Chandy, A.; Schmukler, S. Depression during pregnancy and postpartum. Curr. Psychiatry Rep. 2016, 18, 32. [Google Scholar] [CrossRef] [PubMed]
  4. Lancaster, C.A.; Gold, K.J.; Flynn, H.A.; Yoo, H.; Marcus, S.M.; Davis, M.M. Risk factors for depressive symptoms during pregnancy: A systematic review. Am. J. Obstet. Gynecol. 2010, 202, 5–14. [Google Scholar] [CrossRef] [Green Version]
  5. Míguez, M.C.; Vázquez, M.B. Risk factors for antenatal depression: A review. World J. Psychiatry 2021, 11, 325–336. [Google Scholar] [CrossRef]
  6. Rihmer, Z.; Akiskal, K.K.; Rihmer, A.; Akiskal, H.S. Current research on affective temperaments. Curr. Opin. Psychiatry 2010, 23, 12–18. [Google Scholar] [CrossRef]
  7. Akiskal, H.S.; Akiskal, K.K.; Haykal, R.F.; Manning, J.S.; Connor, P.D. TEMPS-A: Progress towards validation of a self-rated clinical version of the Temperament Evaluation of the Memphis, Pisa, Paris, and San Diego Autoquestionnaire. J. Affect. Disord. 2005, 85, 3–16. [Google Scholar] [CrossRef]
  8. Solmi, M.; Zaninotto, L.; Toffanin, T.; Veronese, N.; Lin, K.; Stubbs, B.; Fornaro, M.; Correll, C.U. A comparative meta-analysis of TEMPS scores across mood disorder patients, their first-degree relatives, healthy controls, and other psychiatric disorders. J. Affect. Disord. 2016, 196, 32–46. [Google Scholar] [CrossRef] [Green Version]
  9. Gonda, X.; Vázquez, G.H. Theoretical and clinical overview of affective temperaments in mood disorders. Psicodebate 2014, 14, 39–58. [Google Scholar] [CrossRef] [Green Version]
  10. Paykel, E.S.; Emms, E.M.; Fletcher, J.; Rassaby, E.S. Life events and social support in puerperal depression. Br. J. Psychiatry 1980, 136, 339–346. [Google Scholar] [CrossRef]
  11. Hirschfeld, R.M.; Williams, J.B.; Spitzer, R.L.; Calabrese, J.R.; Flynn, L.; Keck, P.E.; Lewis, L.; McElroy, S.L.; Post, R.M.; Rappaport, D.J.; et al. Development and validation of a screening instrument for bipolar spectrum disorder: The Mood Disorder Questionnaire. Am. J. Psychiatry 2000, 157, 1873–1875. [Google Scholar] [CrossRef]
  12. Hirschfeld, R.M.; Holzer, C.; Calabrese, J.R.; Weissman, M.; Reed, M.; Davies, M.; Frye, M.A.; Keck, P.; McElroy, S.; Lewis, L.; et al. Validity of the mood disorder questionnaire: A general population study. Am. J. Psychiatry 2003, 160, 178–180. [Google Scholar] [CrossRef]
  13. Hardoy, M.C.; Cadeddu, M.; Murru, A.; Dell’Osso, B.; Carpiniello, B.; Morosini, P.L.; Calabrese, J.R.; Carta, M.G. Validation of the Italian version of the “Mood Disorder Questionnaire” for the screening of bipolar disorders. Clin. Pract. Epidemiol. Ment. Health 2005, 1, 8. [Google Scholar] [CrossRef] [Green Version]
  14. Spitzer, R.L.; Kroenke, K.; Williams, J.B. Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999, 282, 1737–1744. [Google Scholar] [CrossRef] [Green Version]
  15. Kroenke, K.; Spitzer, R.L.; Williams, J.B. The PHQ-9: Validity of a brief depression severity measure. J. Gen. Intern. Med. 2001, 16, 606–613. [Google Scholar] [CrossRef]
  16. Mazzotti, E.; Fassone, G.; Picardi, A.; Sagoni, E.; Ramieri, L.; Lega, I.; Camaion, D.; Abeni, D.; Pasquini, P. The Patient Health Questionnaire (PHQ) for the screening of psychiatric disorders: A validation study versus the Structured Clinical Interview for DSM-IV axis I (SCID). Ital. J. Psychopathol. 2003, 9, 235–242. [Google Scholar]
  17. Pompili, M.; Girardi, P.; Tatarelli, R.; Iliceto, P.; de Pisa, E.; Tondo, L.; Akiskal, K.K.; Akiskal, H.S. TEMPS-A (Rome): Psychometric validation of affective temperaments in clinically well subjects in mid- and south Italy. J. Affect. Disord. 2008, 107, 63–75. [Google Scholar] [CrossRef]
  18. Leigh, B.; Milgrom, J. Risk factors for antenatal depression, postnatal depression and parenting stress. BMC Psychiatry 2008, 16, 24. [Google Scholar] [CrossRef] [Green Version]
  19. Alderdice, F.; McNeill, J.; Lynn, F. A systematic review of systematic reviews of interventions to improve maternal mental health and well-being. Midwifery 2013, 29, 389–399. [Google Scholar] [CrossRef]
  20. Tambelli, R.; Trentini, C.; Trovato, A.; Volpi, B. Role of psychosocial risk factors in predicting maternal and paternal depressive symptomatology during pregnancy. Infant Ment. Health J. 2019, 40, 541–556. [Google Scholar] [CrossRef]
  21. Tomfohr-Madsen, L.M.; Racine, N.; Giesbrecht, G.F.; Lebel, C.; Madigan, S. Depression and anxiety in pregnancy during COVID-19: A rapid review and meta-analysis. Psychiatry Res. 2021, 300, 113912. [Google Scholar] [CrossRef] [PubMed]
  22. Firestein, M.R.; Dumitriu, D.; Marsh, R.; Monk, C. Maternal mental health and infant development during the COVID-19 pandemic. JAMA Psychiatry 2022, 79, 1040–1045. [Google Scholar] [CrossRef] [PubMed]
  23. Tuxunjiang, X.; Li, L.; Wumaier, G.; Zhang, W.; Sailike, B.; Jiang, T. The mediating effect of resilience on pregnancy stress and prenatal anxiety in pregnant women. Front. Psychiatry 2022, 13, 961689. [Google Scholar] [CrossRef] [PubMed]
  24. Huang, J.; Xu, L.; Xu, Z.; Luo, Y.; Liao, B.; Li, Y.; Shi, Y. The relationship among pregnancy-related anxiety, perceived social support, family function and resilience in Chinese pregnant women: A structural equation modeling analysis. BMC Womens Health 2022, 22, 546. [Google Scholar] [CrossRef]
  25. Puertas-Gonzalez, J.A.; Mariño-Narvaez, C.; Romero-Gonzalez, B.; Vilar-López, R.; Peralta-Ramirez, M.I. Resilience, stress and anxiety in pregnancy before and throughout the pandemic: A structural equation modelling approach. Curr. Psychol. 2022, 1–11. [Google Scholar] [CrossRef]
  26. Chieffo, D.; Avallone, C.; Serio, A.; Kotzalidis, G.D.; Balocchi, M.; De Luca, I.; Hirsch, D.; Gonsalez Del Castillo, A.; Lanzotti, P.; Marano, G.; et al. Pregnancy-related psychopathology: A comparison between pre-COVID-19 and COVID-19-related social restriction periods. World J. Clin. Cases 2022, 10, 6370–6384. [Google Scholar] [CrossRef]
  27. De Chiara, L.; Angeletti, G.; Anibaldi, G.; Chetoni, C.; Gualtieri, F.; Forcina, F.; Bargagna, P.; Kotzalidis, G.D.; Callovini, T.; Bonito, M.; et al. The impact of the COVID-19 pandemic on postpartum maternal mental health. J. Pers. Med. 2023, 13, 56. [Google Scholar] [CrossRef]
  28. Kim, H.-R.; Kim, S.-M.; Han, D.-H.; Lee, Y.-S. Protective and risk factors for depressive mood and anxiety against occupational stress: Examining temperament character and coping strategy among civil servants. Arch. Environ. Occup. Health 2020, 75, 346–357. [Google Scholar] [CrossRef]
  29. Ju, G.; Lee, J.; Ahn, M.-H.; Lee, J.; Kim, E.-J.; Suh, S.; Chung, S. Effects of depression and resilience of public workers on work-related stress and anxiety in response to the COVID-19 pandemic. J. Korean Med. Sci. 2021, 36, e262. [Google Scholar] [CrossRef]
  30. Fallahchai, R. Occupational stress, dyadic adjustment and quality of work-life in married nurses: Moderating effects of dyadic coping. Int. J. Nurs. Pract. 2022, 28, e13032. [Google Scholar] [CrossRef]
  31. Pietromonaco, P.R.; Overall, N.C.; Powers, S.I. Depressive symptoms, external stress, and marital adjustment: The buffering effect of partner’s responsive behavior. Soc. Psychol. Personal. Sci. 2022, 13, 220–232. [Google Scholar] [CrossRef]
  32. Ren, H.; Ding, Y.; Hu, H.; Gao, T.; Qin, Z.; Hu, Y.; Cao, R.; Liang, L.; Li, C.; Mei, S. Relationships among economic stress, social support, age and quality of life in patients with chronic wounds: A moderated mediation model. J. Adv. Nurs. 2020, 76, 2125–2136. [Google Scholar] [CrossRef]
  33. Voth Schrag, R.J.; Ravi, K.E.; Robinson, S.R. The role of social support in the link between economic abuse and economic hardship. J. Fam. Violence 2020, 35, 85–93. [Google Scholar] [CrossRef]
  34. Monk, J.K.; Ogolsky, B.G.; Rice, T.K.M.; Dennison, R.P.; Ogan, M. The role of family-of-origin environment and discrepancy in conflict behavior on newlywed marital quality. J. Soc. Pers. Relatsh. 2021, 38, 124–147. [Google Scholar] [CrossRef]
  35. Henry, K.L.; Thornberry, T.P.; Lee, R.D. The protective effects of intimate partner relationships on depressive symptomatology among adult parents maltreated as children. J. Adolesc. Health 2015, 57, 150–156. [Google Scholar] [CrossRef] [Green Version]
  36. Mazza, M.; Kotzalidis, G.D.; Avallone, C.; Balocchi, M.; Sessa, I.; De Luca, I.; Hirsch, D.; Simonetti, A.; Janiri, D.; Loi, E.; et al. Depressive symptoms in expecting fathers: Is paternal perinatal depression a valid concept? A systematic review of evidence. J. Pers. Med. 2022, 12, 1598. [Google Scholar] [CrossRef]
  37. Bennett, H.A.; Einarson, A.; Taddio, A.; Gideon, K.; Einarson, T.R. Prevalence of depression during pregnancy: Systematic review. Obstet. Gynecol. 2004, 103, 698–709. [Google Scholar] [CrossRef]
  38. Okagbue, H.I.; Adamu, P.I.; Bishop, S.A.; Oguntunde, P.E.; Opanuga, A.A.; Akhmetshin, E.M. Systematic review of prevalence of antepartum depression during the trimesters of pregnancy. J. Med. Sci. 2019, 7, 1555–1560. [Google Scholar] [CrossRef] [Green Version]
  39. Viguera, A.C.; Tondo, L.; Koukopoulos, A.E.; Reginaldi, D.; Lepri, B.; Baldessarini, R.J. Episodes of mood disorders in 2,252 pregnancies and postpartum periods. Am. J. Psychiatry 2011, 168, 1179–1185. [Google Scholar] [CrossRef]
  40. Kiewa, J.; Meltzer-Brody, S.; Milgrom, J.; Bennett, E.; Mackle, T.; Guintivano, J.; Hickie, I.B.; Colodro-Conde, L.; Medland, S.E.; Martin, N.; et al. Lifetime prevalence and correlates of perinatal depression in a case-cohort study of depression. BMJ Open 2022, 12, e059300. [Google Scholar] [CrossRef]
  41. Yazici, E.; Yuvaci, H.U.; Yazici, A.B.; Cevrioglu, A.S.; Erol, A. Affective temperaments during pregnancy and postpartum period: A click to hyperthymic temperament. Gynecol. Endocrinol. 2018, 34, 265–269. [Google Scholar] [CrossRef] [PubMed]
  42. Wakamatsu, M.; Nakamura, M.; Douchi, T.; Kasugai, M.; Kodama, S.; Sano, A.; Kobayashi, H. Predicting postpartum depression by evaluating temperament during pregnancy. J. Affect. Disord. 2021, 292, 720–724. [Google Scholar] [CrossRef] [PubMed]
  43. Masmoudi, J.; Trabelsi, S.; Charfeddine, F.; Ayed, B.B.; Guermazi, M.; Jaoua, A.; Karam, E.G.; Hantouche, E.G. Evaluation of affective temperaments in the postpartum depressive symptomatology. L’Encéphale 2010, 36S, D14–D21. [Google Scholar] [CrossRef] [PubMed]
  44. De Chiara, L.; Mazza, C.; Ricci, E.; Koukopoulos, A.E.; Kotzalidis, G.D.; Bonito, M.; Callovini, T.; Roma, P.; Angeletti, G. The relevance of insomnia in the diagnosis of perinatal depression: Validation of the Italian version of the Insomnia Symptom Questionnaire. Int. J. Environ. Res. Public Health 2021, 18, 12507. [Google Scholar] [CrossRef]
  45. Yazici, E.; Terzi, H.; Bosgelmez, S.; Yazici, A.B.; Zincir, S.B.; Kale, A. Affective temperaments in pregnancy. Gynecol. Endocrinol. 2014, 30, 894–898. [Google Scholar] [CrossRef]
Jpm 13 00211 g001 550
Figure 1. PHQ-9 scores. Groups subdivided according to the 4 cut-off. Bars represent standard deviation.
Figure 1. PHQ-9 scores. Groups subdivided according to the 4 cut-off. Bars represent standard deviation.
Jpm 13 00211 g001
Table
Table 1. Sociodemographic variables, epidemiologic characteristics, and temperament scores in the entire sample (n = 193).
Table 1. Sociodemographic variables, epidemiologic characteristics, and temperament scores in the entire sample (n = 193).
ParameterPHQ-9 ≤4 (n = 113)PHQ-9 > 4 (n = 80)χ2 or Fdfp Value
Age, yr (mean ± SD)35.39 ± 5.5033.77 ± 6.07F = 3.5810.060
Gestational age, trimester (n (%))
   I9 (8%)16 (20%)χ2 = 6.3220.042
   II79 (69.9%)51 (63.7%)
   III25 (22.1%)13 (16.3%)
Educational level (yr) (n (%))
   ≤1356 (49.6%)38 (47.5%)χ2 = 0.079410.778
   >1357 (50.4%)42 (52.5%)
Occupation (n (%))
   Yes81 (71.7%)45 (56.3%)χ2 = 4.9210.027
   No32 (28.3%)35 (43.7%)
Partner (n (%))
   Yes112 (99.1%)75 (93.8%)χ2 = 4.4810.034
   No1 (0.9%)5 (6.2%)
Past pregnancies (n (%))
   Yes71 (62.8%)50 (62.5%)χ2 = 0.0022110.963
   No42 (37.2%)30 (37.5%)
Abortions (n (%)) *
   Yes34 (30.1%)22 (27.5%)χ2 = 0.15210.696
   No79 (69.9%)58 (72.5%)
Medical conditions (lifetime) (n (%))
   Yes27 (23.9%)30 (37.5%)χ2 = 4.1710.041
   No86 (76.1%)50 (62.5%)
Psychiatric disorders (lifetime) (n (%))
   Yes15 (13.3%)27 (33.7%)χ2 = 11.51<0.001
   No98 (86.7%)53 (66.3%)
Family psychiatric history (n (%))
   Yes32 (28.3%)36 (45%)χ2 = 5.7110.017
   No81 (71.7%)44 (55%)
Stressful life events (n (%))
   Yes52 (46%)50 (62.5%)χ2 =5.1110.024
   No61 (54%)30 (37.5%)
Support (n (%))
   Yes108 (95.6%)78 (97.5%)χ2 = 0.49610.481
   No5 (4.4%)2 (2.5%)
Psychometric assessment ( x ¯ ± SD)
TEMPS-A depressive4.89 ± 2.018.14 ± 4.13F = 42.201<0.001
TEMPS-A cyclothymic2.42 ± 2.334.31 ± 3.71F = 16.361<0.001
TEMPS-A hyperthymic11.10 ± 3.858.65 ± 4.31F = 16.491<0.001
TEMPS-A irritable1.32 ± 1.863.24 ± 3.34F = 21.661<0.001
TEMPS-A anxious4.04 ± 3.488.09 ± 5.03F = 38.601<0.001
Significant results in bold characters at last column. * 31 spontaneous, 3 planned in the PHQ-9 ≤4 group and 20 spontaneous and 2 planned in the PHQ-9 >4 group (χ2 = 0.0012; p = 0.973, not significant). Abbreviations: df, degrees of freedom; F, ANOVA’s coefficient; PHQ-9, Patient Health Questionnaire-9; SD, standard deviation; TEMPS-A, Temperament Evaluation of Memphis, Pisa, Paris and San Diego-Autoquestionnaire; x ¯ , mean, χ2, chi-square.
Table
Table 2. Logistic regression.
Table 2. Logistic regression.
ParameterOdds Ratio95% C.I.p Value
TEMPS-A depressive1.3101.079 to 1.5910.006
TEMPS-A cyclothymic1.0680.889 to 1.2840.481
TEMPS-A hyperthymic0.8710.790 to 0.9600.005
TEMPS-A irritable1.0030.808 to 1.2440.981
TEMPS-A anxious1.0950.959 to 1.2510.179
Trimester0.6670.340 to 1.3060.237
Occupation0.5730.258 to 1.2740.172
Medical conditions1.7100.751 to 3.8930.202
Psychiatric disorders1.2770.482 to 3.3840.623
Family psychiatric history1.0980.480 to 2.5130.824
Stressful life events0.7330.329 to 1.6350.449
Partner0.1600.014 to 1.8200.140
Significant results in bold characters. Abbreviations: TEMPS-A, Temperament Evaluation of Memphis, Pisa, Paris and San Diego-Autoquestionnaire, 95% C.I., 95% confidence intervals.
Table
Table 3. Significant correlations between two TEMPS-A scales and the total score on the PHQ-9.
Table 3. Significant correlations between two TEMPS-A scales and the total score on the PHQ-9.
TEMPS-A DepressiveTEMPS-A HyperthymicPHQ-9 Score
TEMPS-A Depressive----
TEMPS-A Hyperthymicr = −0.257, p < 0.001----
PHQ-9 scorer = 0.598, p < 0.0001r = −0.251, p < 0.001-----
Abbreviations: TEMPS-A: Temperament Evaluation of Memphis, Pisa, Paris and San Diego-Autoquestionnaire; PHQ-9: Patient Health Questionnaire-9.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Mazza, M.; Avallone, C.; Kotzalidis, G.D.; Marano, G.; Moccia, L.; Serio, A.M.; Balocchi, M.; Sessa, I.; Janiri, D.; De Luca, I.; et al. Depressive Symptoms during Pregnancy: Prevalence and Correlates with Affective Temperaments and Psychosocial Factors. J. Pers. Med. 2023, 13, 211. https://doi.org/10.3390/jpm13020211

AMA Style

Mazza M, Avallone C, Kotzalidis GD, Marano G, Moccia L, Serio AM, Balocchi M, Sessa I, Janiri D, De Luca I, et al. Depressive Symptoms during Pregnancy: Prevalence and Correlates with Affective Temperaments and Psychosocial Factors. Journal of Personalized Medicine. 2023; 13(2):211. https://doi.org/10.3390/jpm13020211

Chicago/Turabian Style

Mazza, Marianna, Carla Avallone, Georgios Demetrios Kotzalidis, Giuseppe Marano, Lorenzo Moccia, Anna Maria Serio, Marta Balocchi, Ilenia Sessa, Delfina Janiri, Ilaria De Luca, and et al. 2023. "Depressive Symptoms during Pregnancy: Prevalence and Correlates with Affective Temperaments and Psychosocial Factors" Journal of Personalized Medicine 13, no. 2: 211. https://doi.org/10.3390/jpm13020211

APA Style

Mazza, M., Avallone, C., Kotzalidis, G. D., Marano, G., Moccia, L., Serio, A. M., Balocchi, M., Sessa, I., Janiri, D., De Luca, I., Brisi, C., Spera, M. C., Monti, L., Gonsalez del Castillo, A., Angeletti, G., Chieffo, D., Rinaldi, L., Janiri, L., Lanzone, A., ... Sani, G. (2023). Depressive Symptoms during Pregnancy: Prevalence and Correlates with Affective Temperaments and Psychosocial Factors. Journal of Personalized Medicine, 13(2), 211. https://doi.org/10.3390/jpm13020211

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop